Prediction of hepatic drug clearance with a human microfluidic four-cell liver acinus microphysiology system
- 17 September 2021
- journal article
- research article
- Published by Elsevier BV in Toxicology
- Vol. 463, 152954
- https://doi.org/10.1016/j.tox.2021.152954
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Organotypic liver culture models: Meeting current challenges in toxicity testingCritical Reviews in Toxicology, 2012
- Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug DevelopmentThe AAPS Journal, 2009
- Validation of a Rapid Equilibrium Dialysis Approach for the Measurement of Plasma Protein BindingJournal of Pharmaceutical Sciences, 2008
- The pharmacokinetics of pioglitazone in patients with impaired renal functionBritish Journal of Clinical Pharmacology, 2003
- Clinical pharmacokinetics of pioglitazoneExperimental and Clinical Endocrinology & Diabetes, 2000
- Steady-State Pharmacokinetics and Dose Proportionality of Troglitazone and Its MetabolitesThe Journal of Clinical Pharmacology, 1999
- Lack of Effect of Type II Diabetes on the Pharmacokinetics of Troglitazone in a Multiple-Dose StudyThe Journal of Clinical Pharmacology, 1997
- Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteersJournal of Antimicrobial Chemotherapy, 1996
- Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteersJournal of Antimicrobial Chemotherapy, 1995
- TerfenadineDrugs, 1990